Ready-to-use Therapeutic Food and Supplementary Food Market Research Report 2033

Ready-to-use Therapeutic Food and Supplementary Food Market Research Report 2033

Segments - by Product Type (Ready-to-use Therapeutic Food, Ready-to-use Supplementary Food), by Form (Paste, Bar, Biscuit, Powder, Others), by Application (Malnutrition Treatment, Emergency Relief, Dietary Supplements, Others), by End User (Children, Adults), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores, Others)

https://growthmarketreports.com/Anuradha
Author : Anuradha B. More
https://growthmarketreports.com/Vaibhav
Fact-checked by : Vaibhav Chandola
https://growthmarketreports.com/Shruti
Editor : Shruti Bhat

Upcoming | Report ID :FB-5719 | 4.2 Rating | 92 Reviews | 277 Pages | Format : Docx PDF

Report Description


Ready-to-use Therapeutic Food and Supplementary Food Market Outlook

As per our latest research, the global Ready-to-use Therapeutic Food and Supplementary Food market size reached USD 5.2 billion in 2024, demonstrating robust growth driven by increasing demand for rapid malnutrition intervention and emergency food solutions. The market is expected to grow at a CAGR of 8.1% from 2025 to 2033, with the forecasted market size anticipated to reach USD 10.2 billion by 2033. The expansion is primarily fueled by a surge in humanitarian aid programs, government initiatives targeting malnutrition, and rising awareness of the benefits of ready-to-use therapeutic and supplementary foods in both developing and developed economies.

One of the core growth drivers for the Ready-to-use Therapeutic Food and Supplementary Food market is the escalating prevalence of acute and chronic malnutrition worldwide. Malnutrition, particularly among children under five years of age, remains a significant public health concern in regions such as Sub-Saharan Africa and South Asia. The World Health Organization and UNICEF have increasingly endorsed the use of ready-to-use therapeutic foods (RUTF) and ready-to-use supplementary foods (RUSF) for community-based management of acute malnutrition. These products offer a convenient, shelf-stable, and nutritionally dense solution that does not require refrigeration or preparation, making them highly valuable in resource-limited settings. The growing support from international organizations and governments for the deployment of RUTF and RUSF in malnutrition treatment programs is expected to sustain market growth over the forecast period.

Another significant factor contributing to market growth is the rising frequency of natural disasters, conflicts, and humanitarian crises that create urgent needs for emergency food relief. Ready-to-use therapeutic and supplementary foods have become the cornerstone of emergency nutrition interventions due to their portability, ease of distribution, and long shelf life. In addition, advancements in food technology have led to the development of improved formulations that cater to specific nutritional needs, such as micronutrient-enriched bars and pastes suitable for both children and adults. The increasing collaboration between non-governmental organizations, food manufacturers, and governmental agencies has facilitated the rapid distribution and adoption of these products in affected regions, further boosting market expansion.

The market is also being propelled by a growing awareness of preventive healthcare and dietary supplementation among consumers in developed economies. Ready-to-use supplementary foods are increasingly being utilized as dietary supplements, not only for malnutrition but also for general health and wellness, especially among vulnerable populations such as the elderly and pregnant women. The rise of e-commerce and online pharmacies has made these products more accessible to a broader audience, while ongoing research and innovation continue to enhance their nutritional profiles and palatability. This trend, coupled with supportive regulatory frameworks and increased investment in nutrition-focused public health campaigns, is expected to further accelerate market growth.

Regionally, the Ready-to-use Therapeutic Food and Supplementary Food market exhibits significant variation in adoption and demand. While Sub-Saharan Africa and South Asia represent the largest markets due to the high burden of malnutrition and frequent humanitarian emergencies, North America and Europe are witnessing growing demand driven by increased health consciousness and the integration of these foods into dietary supplement regimens. Asia Pacific, in particular, is expected to register the highest CAGR during the forecast period, supported by expanding government nutrition programs, rising disposable incomes, and a burgeoning population base. The Middle East and Latin America also present substantial growth opportunities, especially in the context of ongoing nutrition and disaster relief initiatives.

Global Ready-to-use Therapeutic Food and Supplementary Food Industry Outlook

Product Type Analysis

The Product Type segment of the Ready-to-use Therapeutic Food and Supplementary Food market is broadly categorized into Ready-to-use Therapeutic Food (RUTF) and Ready-to-use Supplementary Food (RUSF). RUTF products are specifically formulated for the treatment of severe acute malnutrition and are typically prescribed as a complete food source for affected individuals, particularly children. These products are nutritionally balanced, energy-dense, and fortified with essential vitamins and minerals, enabling quick recovery from malnutrition without the need for hospitalization. In contrast, RUSF products are designed to prevent and treat moderate acute malnutrition and can be used as a supplement to the regular diet. The growing adoption of both RUTF and RUSF in community-based nutrition programs has significantly contributed to the overall expansion of this market segment.

RUTF has traditionally dominated the product type segment, accounting for a significant share of the global market revenue in 2024. This dominance is attributed to the widespread recognition of RUTF by international health organizations as the gold standard for treating severe acute malnutrition. The development of innovative RUTF formulations, such as those based on alternative protein sources and locally available ingredients, has further enhanced their accessibility and cost-effectiveness. Moreover, the increasing prevalence of severe acute malnutrition in conflict and disaster-prone regions continues to drive demand for RUTF, with governments and NGOs ramping up procurement and distribution efforts.

On the other hand, the RUSF segment is experiencing rapid growth, buoyed by its expanding application in both emergency and preventive nutrition programs. RUSF products are gaining traction as an effective means of addressing micronutrient deficiencies and supporting the nutritional needs of at-risk populations, including pregnant and lactating women, the elderly, and individuals with chronic illnesses. The versatility of RUSF, which can be consumed as a snack or meal supplement, has broadened its appeal across diverse demographic segments. Furthermore, ongoing research into novel formulations, such as plant-based and allergen-free options, is expected to enhance the market potential of RUSF in the coming years.

The competitive landscape within the product type segment is characterized by a mix of established multinational players and emerging local manufacturers. Leading companies are focusing on product innovation, strategic partnerships, and capacity expansion to strengthen their market position. The increasing emphasis on sustainable sourcing, ethical production practices, and compliance with international quality standards is also shaping the competitive dynamics of this segment. As the demand for both RUTF and RUSF continues to rise, manufacturers are investing in research and development to create products that are not only nutritionally superior but also culturally acceptable and affordable for target populations.

Report Scope

Attributes Details
Report Title Ready-to-use Therapeutic Food and Supplementary Food Market Research Report 2033
By Product Type Ready-to-use Therapeutic Food, Ready-to-use Supplementary Food
By Form Paste, Bar, Biscuit, Powder, Others
By Application Malnutrition Treatment, Emergency Relief, Dietary Supplements, Others
By End User Children, Adults
By Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Stores, Others
Regions Covered North America, Europe, APAC, Latin America, MEA
Base Year 2024
Historic Data 2018-2023
Forecast Period 2025-2033
Number of Pages 277
Number of Tables & Figures 273
Customization Available Yes, the report can be customized as per your need.

Form Analysis

The Form segment of the Ready-to-use Therapeutic Food and Supplementary Food market encompasses various product formats, including paste, bar, biscuit, powder, and others. Among these, paste-based products have historically dominated the market due to their ease of consumption, high energy density, and suitability for individuals with compromised appetite or digestive function. Paste formulations are particularly favored in the treatment of severe acute malnutrition among young children, as they can be consumed directly from the sachet without the need for preparation or water. The convenience and palatability of paste-based products have made them a staple in emergency nutrition interventions and community-based treatment programs.

Bar and biscuit formats are gaining popularity, especially in supplementary feeding programs and as dietary supplements for older children and adults. These products offer a portable and convenient source of nutrition, making them ideal for use in school feeding programs, workplace wellness initiatives, and on-the-go consumption. The growing demand for fortified snack bars and biscuits, enriched with essential vitamins, minerals, and protein, is driving innovation in this segment. Manufacturers are increasingly focusing on developing products with improved taste, texture, and nutritional profiles to cater to evolving consumer preferences and dietary requirements.

Powdered ready-to-use foods represent another important segment, offering versatility and extended shelf life. Powder formulations can be easily reconstituted with water or milk, providing a flexible option for both therapeutic and supplementary feeding. These products are particularly useful in settings where storage and transportation of bulky or perishable items are challenging. Advances in food processing technology have enabled the development of nutrient-dense powdered formulations that retain their efficacy and palatability over prolonged periods. The growing adoption of powdered ready-to-use foods in institutional and home-based nutrition programs is expected to drive further growth in this segment.

Other forms, such as liquid and gel-based ready-to-use foods, are also emerging as viable options, particularly for populations with specific medical or dietary needs. These products are designed to address challenges related to swallowing difficulties, allergies, and intolerances, expanding the market reach of ready-to-use therapeutic and supplementary foods. The ongoing diversification of product formats, coupled with advancements in packaging and preservation technologies, is expected to enhance the accessibility and appeal of these products across a wide range of end users and applications.

Application Analysis

The Application segment of the Ready-to-use Therapeutic Food and Supplementary Food market is segmented into malnutrition treatment, emergency relief, dietary supplements, and others. Malnutrition treatment remains the primary application, accounting for the largest share of market revenue in 2024. The effectiveness of ready-to-use therapeutic and supplementary foods in the rapid rehabilitation of severely and moderately malnourished individuals has been well-documented, driving their widespread adoption in both clinical and community settings. The integration of these products into national and international nutrition programs has played a pivotal role in reducing mortality and morbidity associated with malnutrition, particularly among children under five years of age.

Emergency relief is another critical application area, with ready-to-use foods serving as an essential component of humanitarian aid during natural disasters, conflicts, and other crises. The ability of these products to provide immediate, life-saving nutrition in challenging environments has made them indispensable for relief organizations and government agencies. The increasing frequency and severity of humanitarian emergencies worldwide have underscored the importance of maintaining robust supply chains and stockpiles of ready-to-use therapeutic and supplementary foods for rapid deployment.

Dietary supplementation is an emerging application, particularly in developed markets where consumers are increasingly seeking convenient and effective ways to enhance their nutritional intake. Ready-to-use supplementary foods are being incorporated into wellness and preventive healthcare regimens, targeting populations such as athletes, the elderly, and individuals with specific dietary needs. The growing popularity of fortified snack bars, meal replacements, and functional foods is driving innovation in this segment, with manufacturers developing products tailored to diverse consumer preferences and health goals.

Other applications, such as use in clinical nutrition, maternal health, and chronic disease management, are also gaining traction. The versatility and adaptability of ready-to-use therapeutic and supplementary foods make them suitable for a wide range of nutritional interventions, from hospital-based care to community outreach programs. As research continues to uncover new benefits and applications for these products, the market is expected to witness further diversification and expansion across multiple sectors.

End User Analysis

The End User segment of the Ready-to-use Therapeutic Food and Supplementary Food market is primarily divided into children and adults. Children, particularly those under the age of five, represent the largest end user group, reflecting the high burden of malnutrition and the prioritization of pediatric nutrition in global health initiatives. Ready-to-use therapeutic and supplementary foods have been instrumental in reducing child mortality and improving developmental outcomes in vulnerable populations. The widespread adoption of these products in child health and nutrition programs, supported by government and non-governmental organizations, has been a key driver of market growth in this segment.

Adults constitute a growing segment of the market, driven by increasing awareness of the importance of adequate nutrition across the lifespan. Ready-to-use supplementary foods are being used to address the nutritional needs of pregnant and lactating women, the elderly, individuals with chronic illnesses, and those recovering from surgery or illness. The convenience, portability, and nutritional completeness of these products make them an attractive option for adults seeking to improve their dietary intake or manage specific health conditions. The expansion of adult-focused product lines, including specialized formulations for different life stages and health needs, is expected to drive further growth in this segment.

The end user landscape is also evolving in response to demographic shifts, urbanization, and changing lifestyles. As populations age and the prevalence of non-communicable diseases rises, there is a growing demand for nutrition solutions that support healthy aging, disease prevention, and recovery. Manufacturers are responding by developing products that cater to the unique nutritional requirements of different age groups and health conditions, leveraging advances in nutritional science and food technology.

The increasing involvement of healthcare professionals in recommending and prescribing ready-to-use therapeutic and supplementary foods is further enhancing market penetration among both children and adults. Collaborative efforts between healthcare providers, nutritionists, and manufacturers are helping to raise awareness, improve access, and ensure the appropriate use of these products in diverse settings. As the benefits of ready-to-use foods become more widely recognized, the market is poised for continued growth across all end user segments.

Distribution Channel Analysis

The Distribution Channel segment of the Ready-to-use Therapeutic Food and Supplementary Food market includes hospital pharmacies, retail pharmacies, online stores, and others. Hospital pharmacies have traditionally been the primary distribution channel, particularly for therapeutic foods used in the treatment of severe and moderate acute malnutrition. The involvement of healthcare professionals in prescribing and dispensing these products ensures their appropriate use and monitoring, contributing to positive treatment outcomes. Hospital pharmacies also play a critical role in emergency response efforts, facilitating the rapid distribution of ready-to-use foods during crises.

Retail pharmacies are emerging as an important distribution channel, especially for supplementary foods and dietary supplements. The increasing availability of ready-to-use products in retail settings has improved access for consumers seeking convenient nutrition solutions for themselves and their families. Retail pharmacies offer the advantage of professional guidance and support, helping consumers make informed choices about product selection and use. The expansion of retail pharmacy networks, particularly in developing regions, is expected to drive further growth in this segment.

Online stores represent a rapidly growing distribution channel, driven by the increasing adoption of e-commerce and digital health platforms. The convenience of online shopping, coupled with the ability to access a wide range of products and information, has made online stores an attractive option for consumers seeking ready-to-use therapeutic and supplementary foods. The COVID-19 pandemic has accelerated the shift towards online purchasing, with manufacturers and retailers investing in digital marketing, direct-to-consumer sales, and home delivery services to meet growing demand. The online channel is particularly well-suited for reaching remote or underserved populations, expanding market reach and accessibility.

Other distribution channels, such as community health centers, non-governmental organizations, and government agencies, play a vital role in ensuring the equitable distribution of ready-to-use foods, particularly in low-resource settings. These channels are often involved in large-scale nutrition programs, emergency relief efforts, and targeted interventions for vulnerable populations. The integration of multiple distribution channels, supported by robust supply chain management and logistics infrastructure, is essential for ensuring the timely and efficient delivery of ready-to-use therapeutic and supplementary foods to those in need.

Opportunities & Threats

The Ready-to-use Therapeutic Food and Supplementary Food market presents a wealth of opportunities for growth and innovation. One of the most promising opportunities lies in the development of new product formulations that cater to diverse nutritional needs and preferences. Advances in food science and technology are enabling manufacturers to create products that are not only nutritionally complete but also tailored to specific life stages, health conditions, and cultural dietary patterns. The growing demand for plant-based, allergen-free, and fortified products is driving innovation and expanding the market potential of ready-to-use foods. Additionally, the increasing focus on sustainable sourcing, ethical production, and environmental stewardship presents opportunities for companies to differentiate themselves and appeal to socially conscious consumers and institutional buyers.

Another significant opportunity is the expansion of market reach through strategic partnerships and collaborations with governments, non-governmental organizations, and international agencies. By leveraging the expertise, resources, and distribution networks of these stakeholders, manufacturers can enhance the accessibility and affordability of ready-to-use therapeutic and supplementary foods in high-need regions. The integration of ready-to-use foods into national nutrition policies, school feeding programs, and maternal and child health initiatives offers a pathway to sustained market growth and impact. Furthermore, the increasing adoption of digital health and e-commerce platforms provides new avenues for reaching consumers and delivering personalized nutrition solutions.

Despite the numerous opportunities, the market faces several restraining factors that could limit growth. One of the primary challenges is the high cost of ready-to-use therapeutic and supplementary foods, particularly in low-income countries where purchasing power is limited. The reliance on imported raw materials, complex manufacturing processes, and stringent quality control requirements contribute to elevated production costs, making these products less accessible to vulnerable populations. Additionally, logistical challenges related to storage, transportation, and distribution in remote or conflict-affected areas can impede the timely delivery of ready-to-use foods. Addressing these barriers will require concerted efforts from all stakeholders, including investment in local production, supply chain optimization, and innovative financing mechanisms.

Regional Outlook

The regional analysis of the Ready-to-use Therapeutic Food and Supplementary Food market reveals marked differences in market size, growth rates, and adoption patterns. In 2024, Sub-Saharan Africa emerged as the largest regional market, accounting for approximately USD 2.1 billion in revenue, driven by the high prevalence of malnutrition and the extensive deployment of RUTF and RUSF in humanitarian and government-led nutrition programs. The region continues to benefit from strong support from international organizations, donor agencies, and NGOs, which are instrumental in funding, procuring, and distributing ready-to-use foods to vulnerable populations. Despite ongoing challenges related to infrastructure and logistics, Sub-Saharan Africa is expected to maintain its dominant position over the forecast period.

The Asia Pacific region is poised for the fastest growth, with a projected CAGR of 10.2% from 2025 to 2033. The market size for Asia Pacific was estimated at USD 1.4 billion in 2024, with significant contributions from countries such as India, Bangladesh, and Indonesia, where government and NGO-led nutrition initiatives are gaining momentum. The region's large and growing population, combined with rising awareness of malnutrition and increasing investments in healthcare infrastructure, is expected to drive robust demand for ready-to-use therapeutic and supplementary foods. The expansion of e-commerce and retail distribution channels is further enhancing market accessibility and penetration, particularly in urban and semi-urban areas.

In North America and Europe, the market is characterized by a growing focus on dietary supplementation, preventive healthcare, and wellness. The combined market size for these regions was approximately USD 1.3 billion in 2024, with steady growth expected over the forecast period. The increasing integration of ready-to-use supplementary foods into mainstream health and wellness regimens, coupled with the rise of functional foods and personalized nutrition, is driving demand among health-conscious consumers. The presence of established manufacturers, advanced research and development capabilities, and supportive regulatory frameworks further contribute to market growth in these regions. Meanwhile, Latin America and the Middle East & Africa regions, with a combined market value of USD 0.4 billion in 2024, are expected to witness gradual growth, supported by expanding nutrition programs and increasing international aid.

Ready-to-use Therapeutic Food and Supplementary Food Market Statistics

Competitor Outlook

The competitive landscape of the Ready-to-use Therapeutic Food and Supplementary Food market is characterized by the presence of a diverse array of multinational corporations, regional players, and specialized manufacturers. Leading companies are distinguished by their strong research and development capabilities, robust supply chain networks, and extensive experience in large-scale production and distribution of ready-to-use foods. The market is highly dynamic, with ongoing innovation in product formulations, packaging, and delivery mechanisms aimed at enhancing nutritional efficacy, shelf life, and consumer appeal. Companies are also increasingly focusing on sustainability, ethical sourcing, and compliance with international quality standards to meet the evolving expectations of customers and regulatory authorities.

Strategic collaborations and partnerships are a defining feature of the competitive landscape, as manufacturers seek to expand their market reach and leverage the expertise of governments, NGOs, and international agencies. Joint ventures, licensing agreements, and co-development initiatives are common, enabling companies to access new markets, share risks, and accelerate product development. The growing emphasis on local production and capacity building in high-need regions is fostering the emergence of regional champions and new entrants, intensifying competition and driving innovation. Price competition remains a key challenge, particularly in low-income markets where cost considerations are paramount.

The market is witnessing increasing investment in marketing, brand building, and consumer education, as companies strive to differentiate their offerings and build long-term customer loyalty. Digital marketing, direct-to-consumer sales, and e-commerce platforms are playing an increasingly important role in reaching and engaging consumers, particularly in developed markets. Companies are also investing in research to support health claims, demonstrate product efficacy, and secure regulatory approvals, further enhancing their competitive positioning.

Some of the major companies operating in the Ready-to-use Therapeutic Food and Supplementary Food market include Nutriset, Abbott Laboratories, Valid Nutrition, Mana Nutritive Aid Products, Edesia Nutrition, Tabatchnick Fine Foods, InnoFaso, Hilina Enriched Foods, and Meds & Food for Kids. Nutriset is widely recognized for its pioneering work in the development of Plumpy’Nut, a leading RUTF product used globally in the treatment of severe acute malnutrition. Abbott Laboratories is a key player in the dietary supplement and clinical nutrition segment, leveraging its extensive research and distribution capabilities. Valid Nutrition and Edesia Nutrition are notable for their focus on innovative, sustainable, and locally sourced ready-to-use foods, while Mana Nutritive Aid Products and Meds & Food for Kids are recognized for their contributions to emergency relief and community nutrition programs.

In addition to these major players, a growing number of regional and local manufacturers are entering the market, particularly in Asia and Africa, driven by rising demand and supportive government policies. These companies are often focused on developing culturally appropriate, affordable, and locally produced ready-to-use foods, contributing to market diversification and resilience. The increasing involvement of public-private partnerships, donor agencies, and international organizations is further shaping the competitive dynamics of the market, creating new opportunities for collaboration and innovation.

Overall, the Ready-to-use Therapeutic Food and Supplementary Food market is poised for continued growth and transformation, driven by innovation, collaboration, and a shared commitment to addressing global nutrition challenges. As the market evolves, companies that can successfully balance quality, affordability, and accessibility will be well-positioned to capture a larger share of this rapidly expanding market.

Key Players

  • Nutriset SAS
  • Abbott Laboratories
  • Diva Nutritional Products
  • Valid Nutrition
  • InnoFaso
  • Edesia Nutrition
  • Mana Nutrition
  • Hilina Enriched Foods
  • Meds & Food for Kids
  • Nuflower Foods and Nutrition
  • Tabatchnick Fine Foods
  • GC Rieber Compact AS
  • Power Foods Industries
  • Samriddhi Food Products Pvt Ltd
  • Nutrivita Foods
  • Kaira District Cooperative Milk Producers’ Union (Amul)
  • Samil Industrial Co. Ltd.
  • Compact AS
  • Nuflower Foods
  • BASF SE
Ready-to-use Therapeutic Food and Supplementary Food Market Overview

Segments

The Ready-to-use Therapeutic Food and Supplementary Food market has been segmented on the basis of

Product Type

  • Ready-to-use Therapeutic Food
  • Ready-to-use Supplementary Food

Form

  • Paste
  • Bar
  • Biscuit
  • Powder
  • Others

Application

  • Malnutrition Treatment
  • Emergency Relief
  • Dietary Supplements
  • Others

End User

  • Children
  • Adults

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores
  • Others

Competitive Landscape

Key players competing in the global market are Edesia; Valid Nutrition; Nuflower Foods & Nutrition Pvt. Ltd; InnoFaso; DIVA NUTRITIONAL PRODUCTS; Nutriset; DIVA NUTRITIONAL PRODUCTS; Tabatchnick Fine Foods, Inc; Nutrivita Foods Pvt. Ltd; and Vista Fortifoods Pvt.Ltd.

These companies are boosting their market share by adopting various strategies such as partnerships, mergers, reduction in production costs, launching new products, and implementing advanced technologies.             

  • On September 30, 2022, Abbott, a multinational US-based company, announced the creation of the Abbott Center for Malnutrition Solutions. This innovation hub will have a primary focus on reducing malnutrition on a global scale. The center will work in collaboration with other nutrition experts and partners to address the treatment and prevention of malnutrition in populations worldwide.

    Ready-to-use Therapeutic Food and Supplementary Food Market Key Players

Frequently Asked Questions

These foods are essential in emergency nutrition interventions due to their portability, long shelf life, and ease of distribution, making them ideal for rapid malnutrition intervention and disaster relief efforts.

Major players include Nutriset, Abbott Laboratories, Valid Nutrition, Mana Nutrition, Edesia Nutrition, Tabatchnick Fine Foods, InnoFaso, Hilina Enriched Foods, and Meds & Food for Kids.

Opportunities include innovation in product formulations, expansion via partnerships, and growth in e-commerce. Challenges include high production costs, supply chain logistics, and accessibility in low-income regions.

Distribution channels include hospital pharmacies, retail pharmacies, online stores, community health centers, NGOs, and government agencies.

Children under five are the largest end user group, but there is growing adoption among adults, including pregnant women, the elderly, and individuals with chronic illnesses.

The main product forms include paste, bar, biscuit, powder, and emerging forms like liquid and gel, with paste-based products dominating due to ease of consumption and high energy density.

Sub-Saharan Africa and South Asia are the largest markets due to high malnutrition rates, while Asia Pacific is expected to have the highest CAGR. North America and Europe are also seeing increased demand due to health consciousness.

Key growth drivers include increasing prevalence of malnutrition, rising humanitarian aid and government initiatives, growing awareness of preventive healthcare, and advancements in food technology.

RUTF are nutritionally balanced, energy-dense foods used for the treatment of severe acute malnutrition, especially in children, while RUSF are designed to prevent and treat moderate acute malnutrition and can be used as dietary supplements for at-risk populations.

The global Ready-to-use Therapeutic Food and Supplementary Food market reached USD 5.2 billion in 2024 and is projected to grow at a CAGR of 8.1% from 2025 to 2033, reaching USD 10.2 billion by 2033.

Table Of Content

Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ready-to-use Therapeutic Food and Supplementary Food Market Overview
   4.1 Introduction
      4.1.1 Market Taxonomy
      4.1.2 Market Definition
      4.1.3 Macro-Economic Factors Impacting the Market Growth
   4.2 Ready-to-use Therapeutic Food and Supplementary Food Market Dynamics
      4.2.1 Market Drivers
      4.2.2 Market Restraints
      4.2.3 Market Opportunity
   4.3 Ready-to-use Therapeutic Food and Supplementary Food Market - Supply Chain Analysis
      4.3.1 List of Key Suppliers
      4.3.2 List of Key Distributors
      4.3.3 List of Key Consumers
   4.4 Key Forces Shaping the Ready-to-use Therapeutic Food and Supplementary Food Market
      4.4.1 Bargaining Power of Suppliers
      4.4.2 Bargaining Power of Buyers
      4.4.3 Threat of Substitution
      4.4.4 Threat of New Entrants
      4.4.5 Competitive Rivalry
   4.5 Global Ready-to-use Therapeutic Food and Supplementary Food Market Size & Forecast, 2023-2032
      4.5.1 Ready-to-use Therapeutic Food and Supplementary Food Market Size and Y-o-Y Growth
      4.5.2 Ready-to-use Therapeutic Food and Supplementary Food Market Absolute $ Opportunity

Chapter 5 Global Ready-to-use Therapeutic Food and Supplementary Food Market Analysis and Forecast By Product Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities By Product Type
      5.1.2 Basis Point Share (BPS) Analysis By Product Type
      5.1.3 Absolute $ Opportunity Assessment By Product Type
   5.2 Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Product Type
      5.2.1 Ready-to-use Therapeutic Food
      5.2.2 Ready-to-use Supplementary Food
   5.3 Market Attractiveness Analysis By Product Type

Chapter 6 Global Ready-to-use Therapeutic Food and Supplementary Food Market Analysis and Forecast By Form
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities By Form
      6.1.2 Basis Point Share (BPS) Analysis By Form
      6.1.3 Absolute $ Opportunity Assessment By Form
   6.2 Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Form
      6.2.1 Paste
      6.2.2 Bar
      6.2.3 Biscuit
      6.2.4 Powder
      6.2.5 Others
   6.3 Market Attractiveness Analysis By Form

Chapter 7 Global Ready-to-use Therapeutic Food and Supplementary Food Market Analysis and Forecast By Application
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities By Application
      7.1.2 Basis Point Share (BPS) Analysis By Application
      7.1.3 Absolute $ Opportunity Assessment By Application
   7.2 Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Application
      7.2.1 Malnutrition Treatment
      7.2.2 Emergency Relief
      7.2.3 Dietary Supplements
      7.2.4 Others
   7.3 Market Attractiveness Analysis By Application

Chapter 8 Global Ready-to-use Therapeutic Food and Supplementary Food Market Analysis and Forecast By End User
   8.1 Introduction
      8.1.1 Key Market Trends & Growth Opportunities By End User
      8.1.2 Basis Point Share (BPS) Analysis By End User
      8.1.3 Absolute $ Opportunity Assessment By End User
   8.2 Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By End User
      8.2.1 Children
      8.2.2 Adults
   8.3 Market Attractiveness Analysis By End User

Chapter 9 Global Ready-to-use Therapeutic Food and Supplementary Food Market Analysis and Forecast By Distribution Channel
   9.1 Introduction
      9.1.1 Key Market Trends & Growth Opportunities By Distribution Channel
      9.1.2 Basis Point Share (BPS) Analysis By Distribution Channel
      9.1.3 Absolute $ Opportunity Assessment By Distribution Channel
   9.2 Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Distribution Channel
      9.2.1 Hospital Pharmacies
      9.2.2 Retail Pharmacies
      9.2.3 Online Stores
      9.2.4 Others
   9.3 Market Attractiveness Analysis By Distribution Channel

Chapter 10 Global Ready-to-use Therapeutic Food and Supplementary Food Market Analysis and Forecast by Region
   10.1 Introduction
      10.1.1 Key Market Trends & Growth Opportunities By Region
      10.1.2 Basis Point Share (BPS) Analysis By Region
      10.1.3 Absolute $ Opportunity Assessment By Region
   10.2 Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Region
      10.2.1 North America
      10.2.2 Europe
      10.2.3 Asia Pacific
      10.2.4 Latin America
      10.2.5 Middle East & Africa (MEA)
   10.3 Market Attractiveness Analysis By Region

Chapter 11 Coronavirus Disease (COVID-19) Impact 
   11.1 Introduction 
   11.2 Current & Future Impact Analysis 
   11.3 Economic Impact Analysis 
   11.4 Government Policies 
   11.5 Investment Scenario

Chapter 12 North America Ready-to-use Therapeutic Food and Supplementary Food Analysis and Forecast
   12.1 Introduction
   12.2 North America Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast by Country
      12.2.1 U.S.
      12.2.2 Canada
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 North America Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Product Type
      12.6.1 Ready-to-use Therapeutic Food
      12.6.2 Ready-to-use Supplementary Food
   12.7 Basis Point Share (BPS) Analysis By Product Type 
   12.8 Absolute $ Opportunity Assessment By Product Type 
   12.9 Market Attractiveness Analysis By Product Type
   12.10 North America Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Form
      12.10.1 Paste
      12.10.2 Bar
      12.10.3 Biscuit
      12.10.4 Powder
      12.10.5 Others
   12.11 Basis Point Share (BPS) Analysis By Form 
   12.12 Absolute $ Opportunity Assessment By Form 
   12.13 Market Attractiveness Analysis By Form
   12.14 North America Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Application
      12.14.1 Malnutrition Treatment
      12.14.2 Emergency Relief
      12.14.3 Dietary Supplements
      12.14.4 Others
   12.15 Basis Point Share (BPS) Analysis By Application 
   12.16 Absolute $ Opportunity Assessment By Application 
   12.17 Market Attractiveness Analysis By Application
   12.18 North America Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By End User
      12.18.1 Children
      12.18.2 Adults
   12.19 Basis Point Share (BPS) Analysis By End User 
   12.20 Absolute $ Opportunity Assessment By End User 
   12.21 Market Attractiveness Analysis By End User
   12.22 North America Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Distribution Channel
      12.22.1 Hospital Pharmacies
      12.22.2 Retail Pharmacies
      12.22.3 Online Stores
      12.22.4 Others
   12.23 Basis Point Share (BPS) Analysis By Distribution Channel 
   12.24 Absolute $ Opportunity Assessment By Distribution Channel 
   12.25 Market Attractiveness Analysis By Distribution Channel

Chapter 13 Europe Ready-to-use Therapeutic Food and Supplementary Food Analysis and Forecast
   13.1 Introduction
   13.2 Europe Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast by Country
      13.2.1 Germany
      13.2.2 France
      13.2.3 Italy
      13.2.4 U.K.
      13.2.5 Spain
      13.2.6 Russia
      13.2.7 Rest of Europe
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Europe Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Product Type
      13.6.1 Ready-to-use Therapeutic Food
      13.6.2 Ready-to-use Supplementary Food
   13.7 Basis Point Share (BPS) Analysis By Product Type 
   13.8 Absolute $ Opportunity Assessment By Product Type 
   13.9 Market Attractiveness Analysis By Product Type
   13.10 Europe Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Form
      13.10.1 Paste
      13.10.2 Bar
      13.10.3 Biscuit
      13.10.4 Powder
      13.10.5 Others
   13.11 Basis Point Share (BPS) Analysis By Form 
   13.12 Absolute $ Opportunity Assessment By Form 
   13.13 Market Attractiveness Analysis By Form
   13.14 Europe Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Application
      13.14.1 Malnutrition Treatment
      13.14.2 Emergency Relief
      13.14.3 Dietary Supplements
      13.14.4 Others
   13.15 Basis Point Share (BPS) Analysis By Application 
   13.16 Absolute $ Opportunity Assessment By Application 
   13.17 Market Attractiveness Analysis By Application
   13.18 Europe Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By End User
      13.18.1 Children
      13.18.2 Adults
   13.19 Basis Point Share (BPS) Analysis By End User 
   13.20 Absolute $ Opportunity Assessment By End User 
   13.21 Market Attractiveness Analysis By End User
   13.22 Europe Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Distribution Channel
      13.22.1 Hospital Pharmacies
      13.22.2 Retail Pharmacies
      13.22.3 Online Stores
      13.22.4 Others
   13.23 Basis Point Share (BPS) Analysis By Distribution Channel 
   13.24 Absolute $ Opportunity Assessment By Distribution Channel 
   13.25 Market Attractiveness Analysis By Distribution Channel

Chapter 14 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Analysis and Forecast
   14.1 Introduction
   14.2 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast by Country
      14.2.1 China
      14.2.2 Japan
      14.2.3 South Korea
      14.2.4 India
      14.2.5 Australia
      14.2.6 South East Asia (SEA)
      14.2.7 Rest of Asia Pacific (APAC)
   14.3 Basis Point Share (BPS) Analysis by Country
   14.4 Absolute $ Opportunity Assessment by Country
   14.5 Market Attractiveness Analysis by Country
   14.6 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Product Type
      14.6.1 Ready-to-use Therapeutic Food
      14.6.2 Ready-to-use Supplementary Food
   14.7 Basis Point Share (BPS) Analysis By Product Type 
   14.8 Absolute $ Opportunity Assessment By Product Type 
   14.9 Market Attractiveness Analysis By Product Type
   14.10 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Form
      14.10.1 Paste
      14.10.2 Bar
      14.10.3 Biscuit
      14.10.4 Powder
      14.10.5 Others
   14.11 Basis Point Share (BPS) Analysis By Form 
   14.12 Absolute $ Opportunity Assessment By Form 
   14.13 Market Attractiveness Analysis By Form
   14.14 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Application
      14.14.1 Malnutrition Treatment
      14.14.2 Emergency Relief
      14.14.3 Dietary Supplements
      14.14.4 Others
   14.15 Basis Point Share (BPS) Analysis By Application 
   14.16 Absolute $ Opportunity Assessment By Application 
   14.17 Market Attractiveness Analysis By Application
   14.18 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By End User
      14.18.1 Children
      14.18.2 Adults
   14.19 Basis Point Share (BPS) Analysis By End User 
   14.20 Absolute $ Opportunity Assessment By End User 
   14.21 Market Attractiveness Analysis By End User
   14.22 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Distribution Channel
      14.22.1 Hospital Pharmacies
      14.22.2 Retail Pharmacies
      14.22.3 Online Stores
      14.22.4 Others
   14.23 Basis Point Share (BPS) Analysis By Distribution Channel 
   14.24 Absolute $ Opportunity Assessment By Distribution Channel 
   14.25 Market Attractiveness Analysis By Distribution Channel

Chapter 15 Latin America Ready-to-use Therapeutic Food and Supplementary Food Analysis and Forecast
   15.1 Introduction
   15.2 Latin America Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast by Country
      15.2.1 Brazil
      15.2.2 Mexico
      15.2.3 Rest of Latin America (LATAM)
   15.3 Basis Point Share (BPS) Analysis by Country
   15.4 Absolute $ Opportunity Assessment by Country
   15.5 Market Attractiveness Analysis by Country
   15.6 Latin America Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Product Type
      15.6.1 Ready-to-use Therapeutic Food
      15.6.2 Ready-to-use Supplementary Food
   15.7 Basis Point Share (BPS) Analysis By Product Type 
   15.8 Absolute $ Opportunity Assessment By Product Type 
   15.9 Market Attractiveness Analysis By Product Type
   15.10 Latin America Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Form
      15.10.1 Paste
      15.10.2 Bar
      15.10.3 Biscuit
      15.10.4 Powder
      15.10.5 Others
   15.11 Basis Point Share (BPS) Analysis By Form 
   15.12 Absolute $ Opportunity Assessment By Form 
   15.13 Market Attractiveness Analysis By Form
   15.14 Latin America Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Application
      15.14.1 Malnutrition Treatment
      15.14.2 Emergency Relief
      15.14.3 Dietary Supplements
      15.14.4 Others
   15.15 Basis Point Share (BPS) Analysis By Application 
   15.16 Absolute $ Opportunity Assessment By Application 
   15.17 Market Attractiveness Analysis By Application
   15.18 Latin America Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By End User
      15.18.1 Children
      15.18.2 Adults
   15.19 Basis Point Share (BPS) Analysis By End User 
   15.20 Absolute $ Opportunity Assessment By End User 
   15.21 Market Attractiveness Analysis By End User
   15.22 Latin America Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Distribution Channel
      15.22.1 Hospital Pharmacies
      15.22.2 Retail Pharmacies
      15.22.3 Online Stores
      15.22.4 Others
   15.23 Basis Point Share (BPS) Analysis By Distribution Channel 
   15.24 Absolute $ Opportunity Assessment By Distribution Channel 
   15.25 Market Attractiveness Analysis By Distribution Channel

Chapter 16 Middle East & Africa (MEA) Ready-to-use Therapeutic Food and Supplementary Food Analysis and Forecast
   16.1 Introduction
   16.2 Middle East & Africa (MEA) Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast by Country
      16.2.1 Saudi Arabia
      16.2.2 South Africa
      16.2.3 UAE
      16.2.4 Rest of Middle East & Africa (MEA)
   16.3 Basis Point Share (BPS) Analysis by Country
   16.4 Absolute $ Opportunity Assessment by Country
   16.5 Market Attractiveness Analysis by Country
   16.6 Middle East & Africa (MEA) Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Product Type
      16.6.1 Ready-to-use Therapeutic Food
      16.6.2 Ready-to-use Supplementary Food
   16.7 Basis Point Share (BPS) Analysis By Product Type 
   16.8 Absolute $ Opportunity Assessment By Product Type 
   16.9 Market Attractiveness Analysis By Product Type
   16.10 Middle East & Africa (MEA) Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Form
      16.10.1 Paste
      16.10.2 Bar
      16.10.3 Biscuit
      16.10.4 Powder
      16.10.5 Others
   16.11 Basis Point Share (BPS) Analysis By Form 
   16.12 Absolute $ Opportunity Assessment By Form 
   16.13 Market Attractiveness Analysis By Form
   16.14 Middle East & Africa (MEA) Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Application
      16.14.1 Malnutrition Treatment
      16.14.2 Emergency Relief
      16.14.3 Dietary Supplements
      16.14.4 Others
   16.15 Basis Point Share (BPS) Analysis By Application 
   16.16 Absolute $ Opportunity Assessment By Application 
   16.17 Market Attractiveness Analysis By Application
   16.18 Middle East & Africa (MEA) Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By End User
      16.18.1 Children
      16.18.2 Adults
   16.19 Basis Point Share (BPS) Analysis By End User 
   16.20 Absolute $ Opportunity Assessment By End User 
   16.21 Market Attractiveness Analysis By End User
   16.22 Middle East & Africa (MEA) Ready-to-use Therapeutic Food and Supplementary Food Market Size Forecast By Distribution Channel
      16.22.1 Hospital Pharmacies
      16.22.2 Retail Pharmacies
      16.22.3 Online Stores
      16.22.4 Others
   16.23 Basis Point Share (BPS) Analysis By Distribution Channel 
   16.24 Absolute $ Opportunity Assessment By Distribution Channel 
   16.25 Market Attractiveness Analysis By Distribution Channel

Chapter 17 Competition Landscape 
   17.1 Ready-to-use Therapeutic Food and Supplementary Food Market: Competitive Dashboard
   17.2 Global Ready-to-use Therapeutic Food and Supplementary Food Market: Market Share Analysis, 2023
   17.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      17.3.1 Nutriset SAS
Abbott Laboratories
Diva Nutritional Products
Valid Nutrition
InnoFaso
Edesia Nutrition
Mana Nutrition
Hilina Enriched Foods
Meds & Food for Kids
Nuflower Foods and Nutrition
Tabatchnick Fine Foods
GC Rieber Compact AS
Power Foods Industries
Samriddhi Food Products Pvt Ltd
Nutrivita Foods
Kaira District Cooperative Milk Producers’ Union (Amul)
Samil Industrial Co. Ltd.
Compact AS
Nuflower Foods
BASF SE

Methodology

Our Clients

sinopec
Deloitte
The John Holland Group
General Mills
Honda Motor Co. Ltd.
General Electric
Microsoft
Siemens Healthcare